A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India

NCT07685769 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Treatment of Migraine

Interventions

DRUG: Rimegepant 75 mg ODT

Sponsor

Pfizer